Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration

<i>Background and objectives:</i> Bisphosphonates represent selective inhibitors of excess osteoblastic bone resorption that characterizes all osteopathies, targeting osteoclasts and their precursors. Their long-term administration in postmenopausal women suffering from osteoporosis has...

Full description

Bibliographic Details
Main Authors: Vasileios Alexandros Karakousis, Danai Liouliou, Aikaterini Loula, Nikoleta Kagianni, Eva-Maria Dietrich, Soultana Meditskou, Antonia Sioga, Theodora Papamitsou
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1010-660X/56/3/140
id doaj-78de8dbafa4b42dba1c22d5927f35edb
record_format Article
spelling doaj-78de8dbafa4b42dba1c22d5927f35edb2020-11-25T03:10:06ZengMDPI AGMedicina1010-660X2020-03-0156314010.3390/medicina56030140medicina56030140Immunohistochemical Femoral Nerve Study Following Bisphosphonates AdministrationVasileios Alexandros Karakousis0Danai Liouliou1Aikaterini Loula2Nikoleta Kagianni3Eva-Maria Dietrich4Soultana Meditskou5Antonia Sioga6Theodora Papamitsou7Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceDepartment of Oral and Maxillofacial Surgery, University Hospital of Erlangen, 91054 Erlangen, GermanyLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece<i>Background and objectives:</i> Bisphosphonates represent selective inhibitors of excess osteoblastic bone resorption that characterizes all osteopathies, targeting osteoclasts and their precursors. Their long-term administration in postmenopausal women suffering from osteoporosis has resulted in neural adverse effects. The current study focuses on the research of possible alterations in the femoral nerve, caused by bisphosphonates. We hypothesized that bisphosphonates, taken orally (per os), may produce degenerative changes to the femoral nerve, affecting lower-limb posture and walking neuronal commands. <i>Materials and Methods:</i> In order to support our hypothesis, femoral nerve specimens were extracted from ten female 12-month-old Wistar rats given 0.05 milligrams (mg) per kilogram (kg) of body weight (b.w.) per week alendronate per os for 13 weeks and from ten female 12-month-old Wistar rats given normal saline that were used as a control group. Specimens were studied using immunohistochemistry for selected antibodies NeuN (Neuronal Nuclear Protein), a protein located within mature, postmitotic neural nucleus, and cytosol and Sox10 (Sex-determining Region Y (SRY)&#8212;High-Motility Group (HMG)&#8212;box 10). The latter marker is fundamental for myelination of peripheral nerves. Obtained slides were examined under a light microscope. <i>Results:</i> Samples extracted from rats given alendronate were more Sox10 positive compared to samples of the control group, where the marker&#8217;s expression was not so intense. Both groups were equally NeuN positive. Our results are in agreement with previous studies conducted under a transmission electron microscope. <i>Conclusions:</i> The suggested pathophysiological mechanism linked to histological alterations described above is possibly related to toxic drug effects on Schwann and neuronal cells. Our hypothesis enhances the existing scientific evidence of degenerative changes present on femoral nerve following bisphosphonates administration, indicating a possible relationship between alendronate use and neuronal function.https://www.mdpi.com/1010-660X/56/3/140bisphosphonatesfemoral nerveimmunohistochemistryneunsox10
collection DOAJ
language English
format Article
sources DOAJ
author Vasileios Alexandros Karakousis
Danai Liouliou
Aikaterini Loula
Nikoleta Kagianni
Eva-Maria Dietrich
Soultana Meditskou
Antonia Sioga
Theodora Papamitsou
spellingShingle Vasileios Alexandros Karakousis
Danai Liouliou
Aikaterini Loula
Nikoleta Kagianni
Eva-Maria Dietrich
Soultana Meditskou
Antonia Sioga
Theodora Papamitsou
Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
Medicina
bisphosphonates
femoral nerve
immunohistochemistry
neun
sox10
author_facet Vasileios Alexandros Karakousis
Danai Liouliou
Aikaterini Loula
Nikoleta Kagianni
Eva-Maria Dietrich
Soultana Meditskou
Antonia Sioga
Theodora Papamitsou
author_sort Vasileios Alexandros Karakousis
title Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
title_short Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
title_full Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
title_fullStr Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
title_full_unstemmed Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
title_sort immunohistochemical femoral nerve study following bisphosphonates administration
publisher MDPI AG
series Medicina
issn 1010-660X
publishDate 2020-03-01
description <i>Background and objectives:</i> Bisphosphonates represent selective inhibitors of excess osteoblastic bone resorption that characterizes all osteopathies, targeting osteoclasts and their precursors. Their long-term administration in postmenopausal women suffering from osteoporosis has resulted in neural adverse effects. The current study focuses on the research of possible alterations in the femoral nerve, caused by bisphosphonates. We hypothesized that bisphosphonates, taken orally (per os), may produce degenerative changes to the femoral nerve, affecting lower-limb posture and walking neuronal commands. <i>Materials and Methods:</i> In order to support our hypothesis, femoral nerve specimens were extracted from ten female 12-month-old Wistar rats given 0.05 milligrams (mg) per kilogram (kg) of body weight (b.w.) per week alendronate per os for 13 weeks and from ten female 12-month-old Wistar rats given normal saline that were used as a control group. Specimens were studied using immunohistochemistry for selected antibodies NeuN (Neuronal Nuclear Protein), a protein located within mature, postmitotic neural nucleus, and cytosol and Sox10 (Sex-determining Region Y (SRY)&#8212;High-Motility Group (HMG)&#8212;box 10). The latter marker is fundamental for myelination of peripheral nerves. Obtained slides were examined under a light microscope. <i>Results:</i> Samples extracted from rats given alendronate were more Sox10 positive compared to samples of the control group, where the marker&#8217;s expression was not so intense. Both groups were equally NeuN positive. Our results are in agreement with previous studies conducted under a transmission electron microscope. <i>Conclusions:</i> The suggested pathophysiological mechanism linked to histological alterations described above is possibly related to toxic drug effects on Schwann and neuronal cells. Our hypothesis enhances the existing scientific evidence of degenerative changes present on femoral nerve following bisphosphonates administration, indicating a possible relationship between alendronate use and neuronal function.
topic bisphosphonates
femoral nerve
immunohistochemistry
neun
sox10
url https://www.mdpi.com/1010-660X/56/3/140
work_keys_str_mv AT vasileiosalexandroskarakousis immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
AT danailiouliou immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
AT aikateriniloula immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
AT nikoletakagianni immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
AT evamariadietrich immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
AT soultanameditskou immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
AT antoniasioga immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
AT theodorapapamitsou immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration
_version_ 1724660596386824192